Correspondence 0001213900-23-001438 from Acri Capital Acquisition Corp (ACAC, ACACU, ACACW) (CIK 0001914023)
Acri Capital Acquisition Corp (ACAC, ACACU, ACACW) (CIK 0001914023)
Date: Jan. 6, 2023 · CIK: 0001914023 · Accession: 0001213900-23-001438
AI Filing Summary & Sentiment
File numbers found in text: 001-41415
Referenced dates: January 6, 2023
Letter
Via Edgar Division of Corporation Finance Office of Real Estate & Construction Re: Acri Capital Acquisition Corporation Preliminary Proxy Statement on Schedule 14A Filed December 30, 2022 File No. 001-41415
Dear Ms. Singh:
This letter is in response to the letter dated January 6, 2023, from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) addressed to Acri Capital Acquisition Corporation (the “Company,” “we,” and “our”). For ease of reference, we have recited the Commission’s comments in this response and numbered them accordingly. The amendment to the Preliminary Proxy Statement on Schedule 14A (the “Preliminary Schedule 14A”) is being filed to accompany this letter.
Preliminary Proxy Statement on Schedule 14A
General
1. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.
Response: In response to the Staff’s comments, we added the required disclosures under “We may not be able to complete the business combination if it is subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited” on page 17 of the Preliminary Schedule 14A accordingly.
We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Arila E. Zhou, Esq., of Robinson & Cole LLP, at (212) 451-2908.
Very truly yours,
By:
“Joy” Yi Hua
Show Raw Text
CORRESP
1
filename1.htm
ACRI CAPITAL ACQUISITION CORPORATION
January 6, 2023
Via Edgar
Melanie Singh
Division of Corporation Finance
Office of Real Estate & Construction
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C., 20549
Re:
Acri Capital Acquisition Corporation
Preliminary Proxy Statement on Schedule 14A
Filed December 30, 2022
File No. 001-41415
Dear Ms. Singh:
This letter is in response to the letter dated
January 6, 2023, from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) addressed
to Acri Capital Acquisition Corporation (the “Company,” “we,” and “our”). For ease of reference, we
have recited the Commission’s comments in this response and numbered them accordingly. The amendment to the Preliminary Proxy Statement
on Schedule 14A (the “Preliminary Schedule 14A”) is being filed to accompany this letter.
Preliminary Proxy Statement on Schedule 14A
General
1. With a view toward disclosure, please tell us whether your
sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses
how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that
you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review
by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose
that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further,
disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you
from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors,
such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants,
which would expire worthless.
Response: In response to the Staff’s
comments, we added the required disclosures under “We may not be able to complete the business combination if it is subject to
U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States
(CFIUS), or ultimately prohibited” on page 17 of the Preliminary Schedule 14A accordingly.
We appreciate the assistance the Staff has provided
with its comments. If you have any questions, please do not hesitate to call our counsel, Arila E. Zhou, Esq., of Robinson & Cole
LLP, at (212) 451-2908.
Very truly yours,
By:
“Joy” Yi Hua
“Joy” Yi Hua
Chief Executive Officer
cc: Arila E. Zhou, Esq.
Robinson & Cole LLP